A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients

计划入组 75 人 · 首次发布于 2010 年 12 月 24 日

Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a

计划入组 19 人 · 首次发布于 2005 年 9 月 20 日

First in Human Study of ChAdOx1-HBV in Healthy Participants and Participants With Chronic hepB Infection

计划入组 47 人 · 首次发布于 2020 年 3 月 6 日

HBV

HBV-002

ChAdOx1-HBV

BRII-B

Hong Kong, China

Enanta Pharmaceuticals

United States

DBV Technologies

France

Epigenic Therapeutics' EPI-003 Receives Clearance to Enter Clinical Trials for Chronic Hepatitis B

Precision BioSciences' PBGENE-HBV Receives Clearance for Phase 1 Trial in Chronic Hepatitis B

Tune Therapeutics' TUNE-401, a First-in-Class Epigenetic Silencer, Enters Clinical Trials for Chronic Hepatitis B